Early-stage KRAS G12C-mutated non-small cell lung cancer (NSCLC) in Australia.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.e21053
Abstract: e21053Background: KRAS is frequently mutated in NSCLC, especially in Caucasian populations. Until recently there have not been effective targeted therapies against KRAS but the recent advent of act... read more here.
Keywords: non small; g12c mutated; stage kras; mutated non ... See more keywords